Morgan Stanley raised the firm’s price target on Aperam (APEMY) to EUR 30.30 from EUR 30 and keeps an Equal Weight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APEMY:
- Aperam SA (APEMY) Reveals Q1 Dividend: Here’s the Essential Information
- Aperam price target lowered to EUR 27 from EUR 28 at Barclays
- Aperam Reports Strong 2024 Financial Performance
- Aperam price target lowered to EUR 30 from EUR 32 at Morgan Stanley
- APEMY Earnings Report this Week: Is It a Buy, Ahead of Earnings?